Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL7594621 | 0.91 | — | — | |
| SCHEMBL8369704 | 0.80 | MEN1 (0.32) | — | |
| SCHEMBL14110227 | 0.77 | XDH (0.38) | — | |
| SCHEMBL14260670 | 0.77 | CSNK2A1 (0.32) | DPP4 | |
| SCHEMBL6551675 | 0.75 | DPP4 (0.56) | DPP4 | |
| SCHEMBL15064128 | 0.75 | EGLN1 (0.32) | DPP4 | |
| SCHEMBL5197095 | 0.74 | CYP1A2 (0.39) | — | |
| SCHEMBL15747660 | 0.73 | — | — | |
| SCHEMBL9412739 | 0.73 | MAPT (0.35) | — | |
| SCHEMBL8588214 | 0.73 | KMT2A (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6452004-B1 | USEFUL AS AN INTERMEDIATE OF A CARBOCYCLIC NUCLEOSIDE USEFULLY USED AS AN ANTI-VIRAL AGENT | KURARAY CO., LTD. (JP) | 2002-09-17 | — | — | US | claimed |
| EP-0773220-B1 | 2-Amino-6-chloropurine and method for preparing the same | SUMIKA FINE CHEMICALS CO LTD (JP) | 2002-02-13 | — | — | EP | claimed |
| EP-0861841-B1 | PROCESS FOR PRODUCING 2-AMINO-6-IODOPURINE | SUMIKA FINE CHEMICALS COMPANY (JP) | 2001-04-04 | — | — | EP | claimed |
| US-6127539-A | Cyclopentenecarboxamide derivative, method for preparing the same and bicycloamide derivative used therein | KURARAY CO., LTD. (JP) | 2000-10-03 | — | — | US | claimed |
| US-5994541-A | Process for producing 2-amino-6-iodopurine | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 1999-11-30 | — | — | US | claimed |
| US-5817812-A | Cyclopentenecarboxamide derivative, method for preparing the same and bicycloamide derivative used therein | KURARAY CO., LTD. (JP) | 1998-10-06 | — | — | US | claimed |
| EP-0861841-A1 | PROCESS FOR PRODUCING 2-AMINO-6-IODOPURINE | SUMIKA FINE CHEMICALS Company, Limited (JP) | 1998-09-02 | — | — | EP | claimed |
| US-5789590-A | Double cone-like crystal form of 2-amino-6-chloropurine and preparation | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 1998-08-04 | — | — | US | claimed |
| EP-0773220-A1 | 2-Amino-6-chloropurine and method for preparing the same | SUMIKA FINE CHEMICALS Co., Ltd. (JP) | 1997-05-14 | — | — | EP | claimed |
| JP-10077284-A | — | — | None | — | — | JP | disclosed |
| JP-9188681-A | — | — | None | — | — | JP | disclosed |
| US-20100204463-A1 | Preparation Of Synthetic Nucleosides via Pi-Allyl Transition Metal Complex Formation | EMORY UNIVERSITY | 2010-08-12 | — | — | US | disclosed |
| US-20100204463-A1 | Preparation Of Synthetic Nucleosides via Pi-Allyl Transition Metal Complex Formation | EMORY UNIVERSITY | 2010-08-12 | — | — | US | disclosed |
| EP-1394163-A1 | Bicycloamide derivatives | Kuraray Co., Ltd. (JP) | 2004-03-03 | — | — | EP | disclosed |
| EP-0775705-A2 | Cyclopentenecarboxamide derivative, method for preparing the same and bicycloamide derivative used therein | KURARAY CO., LTD. (JP) | 1997-05-28 | — | — | EP | disclosed |
| EP-0773220-A1 | 2-Amino-6-chloropurine and method for preparing the same | SUMIKA FINE CHEMICALS Co., Ltd. (JP) | 1997-05-14 | — | — | EP | disclosed |
| US-5440037-A | Method for production of 2-amino-6-halogenopurine derivatives | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 1995-08-08 | — | — | US | disclosed |
| US-5391733-A | Synthesis intermediates for 2-amino-6-halogenopurines | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 1995-02-21 | — | — | US | disclosed |
| US-5389637-A | 2-formylamino-6-halogenopurine | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 1995-02-14 | — | — | US | disclosed |
| EP-0543095-A2 | Method for producing 2-amino-6-halogenopurine and synthesis intermediate therefor | SUMIKA FINE CHEMICALS Co., Ltd. (JP) | 1993-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204463-A1 | Preparation Of Synthetic Nucleosides via Pi-Allyl Transition Metal Complex Formation | PAICS, POLRMT, ZC3HAV1 | DPP4 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.